Sat 27 Jul 2024 09:33:47 BST

Search Company

OMS Organisation Identifier:

OMS Location Identifier:

NCA Reference Key:

:

Address:

Country:

*

Active Substance

New Active Substance

Search Site

Create Site

Update Site

Current data stored in EudraGMDP database

Current data stored in OMS

DUNS Number:

--

NCA Reference Key:

Site Name:

OMS Organisation Identifier:

OMS Location Identifier:

Address Line 1:

Address Line 2:

Address Line 3:

Address Line 4:

City:

State:

Postcode:

Country:

Additional Details on Units Inspected

Site under Compliance Management:

Compliance Management comments:

Characters remaining:4000/4000

Overwrite with current OMS data.:

New Active Substance Importation

Active Substance*

Active Substance (English):
Active Substance (NL):
NCA Reference Key:

3rd Country Manufacturer

3rd Country Manufacturer	OMS Location Identifier	OMS Organisation Identifier	Legal Address	NCA Reference Key	Confidential	Edit	Delete
No records found.

3rd Country Distributor

3rd Country Distributor	OMS Location Identifier	OMS Organisation Identifier	Legal Address	NCA Reference Key	Confidential	Edit	Delete
No records found.

Non Compliance Reports

From Date:	(YYYY-MM-DD)*
To Date:	(YYYY-MM-DD)*

Report Number	EudraGMDP Document Reference Number	WDA No./API Reg.No.	OMS Organisation Identifier	OMS Location Identifier	Site Name	Site Address	City	Postcode	Country	Inspection End Date	Issue Date
sukls49149/2024	30562	sukls196264/2021	ORG-100031915	LOC-100068405	Auxilto Healthcare s.r.o.	Podle Trati 624/7, Malesice	Prague	108 00	CZ (Czechia)	2024-05-31	2024-06-27

Loading, please wait

The EudraGMDP database is maintained and operated by the EMA. Access to the general public is granted in order to enhance availability of information related to the EMA mandate. The content of the database is provided by the National Competent Authorities (NCA) of the EEA. For this reason, the EMA accepts no responsibility or liability whatsoever (including but not limited to any direct or consequential loss or damage it might occur to you and/or any other third party) arising out of or in connection with the information on this database. Any questions about the content should be addressed to the relevant NCA.Pleaseclick hereto get list of NCA's.

Due to the restrictions caused by COVID-19, the period of validity of GMP and GDP certificates issued by EEA authorities is automatically extended until the end of 2024, except where clarifying remarks in the document state otherwise. Manufacturers, importers and distributors must continue to comply with GMP/GDP and all other legal obligations. On-site inspections are now being conducted and scheduling of these inspections may be independent of the extended validity period stated above. Competent authorities will continue to perform risk based supervision of sites by either on-site inspections or distant assessments and, based on the outcome, may continue to issue, withdraw or restrict GMP and GDP certificates, as appropriate.

For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI.

Documents issued by UK authorities up to and including 31 December 2020 remain available for consultation in EudraGMDP. However, they are no longer included or updated from 1 January 2021, with the exception of the documents pertaining to sites located in Northern Ireland.

As of 28 January 2022, the source of organisational data will change. Additional information and instructions are available on EMA's website

[EMA © 2014. EudraGMDP6.5.2.3-hotfix build 2024/07/04 09:00]